Sublimity Therapeutics
Sublimity Therapeutics is a clinical-stage biotechnology company dedicated to identifying and developing meaningful new therapies for unmet clinical needs in gastrointestinal and immunological diseases. Led by a team of industry innovators and leveraging our Single-Multiple Pill (SmPill®) technology, we are advancing a diverse pipeline of oral small molecules that have the potential to make important contributions to human health. Our lead asset ST-0529 is currently being evaluated in the AURORA (CYC-202) Study, a Phase 2b clinical trial for moderate to severe Ulcerative Colitis.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
8
51 to 200 range
Open roles
—
no listings
Distinct roles
6
indexed titles
Tech stack
0
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 7 verified contacts at Sublimity Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Sublimity Therapeutics
6 distinct titles indexed · top 6 shown.
- 1analytical scientist
- 1communications manager
- 1director of quality & cmc
- 1quality assurance specialist
- 1senior analytical scientist
- 1senior formulation scientist and ip technical associate
Sign up to unlock all 7 contacts at Sublimity Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Sublimity Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.